Drug recalls

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical I…

SUN PHARMACEUTICAL INDUSTRIES INC · CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Class IICompletedD-0268-2024
Status
Completed
City
Princeton
State
NJ
Country
United States
Classification
Class II
Product type
Drugs
Event ID
93820
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Address 1
2 Independence Way
Address 2
N/A
Postal code
08540-6620
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA
Recall number
D-0268-2024
Product quantity
10,690 bottles
Reason for recall
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Recall initiation date
20240118
Center classification date
20240125
Report date
20240131
Code info
Lot #s: DNE0875A Exp. 01/31/2025; DNE0876A, DNE0877A, DNE1080A, DNE1081A Exp. 02/28/2025; DNE1147A, DNE1148A Exp. 03/31/2025.
Product description

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 63304-175-13.

Harmonized identifiers (openFDA)
Application number
ANDA211858
Brand name
MESALAMINE
Generic name
MESALAMINE
Manufacturer name
Sun Pharmaceutical Industries, Inc.
Product NDC
63304-175
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
MESALAMINE
RxCUI
686429
SPL ID
3f29d761-eab5-4f6b-a4f4-ffcc072648e3
SPL set ID
fd8b02de-7dfa-444d-a1f8-1436b578e0cb
Package NDC
63304-175-13
Is original packager
true
Nui
N0000175781, M0000971
Pharm class epc
Aminosalicylate [EPC]
Pharm class cs
Aminosalicylic Acids [CS]
UNII
4Q81I59GXC
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.